Glenmark Pharmaceuticals
CCI approves Nirma’s acquisition of 75% stake in Glenmark Life Sciences
21 Dec 2023
The Competition Commission of India (CCI) has approved acquisition of majority shareholding of Glenmark Life Sciences (GLS) Limited by the Nirma Limited.
US FDA approves Glenmark's oral contraceptives
24 Feb 2016
HC blocks Glenmark from selling US firm’s diabetes drug
20 Mar 2015
A bench of Justices S Ravindra Bhat and Najmi Waziri, while granting the interim injunction, said Merck Sharp and Dohme "has established a prima facie case of patent infringement" by Glenmark
Glenmark recalls anti-ulcer drug in the US over tablet mix-up
19 Apr 2014
Glenmark Pharmaceuticals Ltd is recalling 2,900 bottles of its anti-ulcer drug ranitidine from the US market after a tablet to treat high blood pressure was found in one of the bottles
Delhi HC refuses interim relief to Merck over Glenmark drug
05 Apr 2013
Glenmark said the US drug firm has no patent rights over ‘Sitagliptin Phosphate’, which is used in its anti-diabetes drugs Zita and Zita-Met
Glenmark wins favourable interim order in deal with Napo
14 Jan 2012
In a significant positive for Glenmark Pharmaceuticals Ltd, its US partner in a drug development and marketing agreement, Napo Pharmaceuticals Inc, will not be able to terminate a deal thanks to an arbitration order
Glenmark to market Crofelemer despite Napo nix
15 Dec 2011
.webp)
.webp)
